PTPI Stock: The Short-Squeeze Buzz That Has Petros Pharmaceuticals Rocketing TodayInvestorPlace • 11/29/21
PTPI Stock: 11 Things to Know About Penny Stock Petros Pharmaceuticals as Shares Rocket 100%+InvestorPlace • 11/23/21
Petros Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate UpdatePRNewsWire • 11/15/21
Petros Pharmaceuticals Expands Program for Novel Investigational Non-Invasive Treatment Formulation for Peyronie's DiseasePRNewsWire • 11/08/21
PTPI Stock: The Huge Reason Little-Known Petros Pharmaceuticals Is Gaining TodayInvestorPlace • 11/03/21
Petros Pharmaceuticals, Inc. Through Exclusive Marketing Agreement with Hims & Hers Health, Inc. Generates 476% Year-Over-Year Growth of STENDRA Tablet SalesPRNewsWire • 11/03/21
Petros Pharmaceuticals Announces Closing of $5.7 Million Registered Direct OfferingPRNewsWire • 10/19/21
Petros Pharmaceuticals to Present at the H.C. Wainwright 23rd Annual Global Investment ConferencePRNewsWire • 09/10/21
Petros Pharmaceuticals Announces Second Quarter Financial Results and Provides Corporate Update; Reports a 123% Increase in Year Over Year Quarterly STENDRA® (avanafil) Net SalesPRNewsWire • 08/17/21
Petros Pharmaceuticals to Present at the Access to Giving Virtual Investor Conference on July 14, 2021PRNewsWire • 07/12/21
Petros Pharmaceuticals to Present at the LD Micro Virtual Invitational Conference on June 10, 2021PRNewsWire • 06/02/21
Petros Pharmaceuticals Announces First Quarter Financial Results and Provides Corporate Update; Reports 300% increase in Year-Over-Year STENDRA Net SalesPRNewsWire • 05/17/21
Petros Pharmaceuticals to Participate at the Investor Summit Conference and Present to Investors on May 18, 2021PRNewsWire • 05/14/21